Pharma channel feed – Endpoints News

Pharma channel feed

Exclusive: Synapticure raises $25M for its approach to virtual neurodegenerative disease care

6 months ago

Syndax's Revuforj wins FDA approval in aggressive form of leukemia

6 months ago

A rare neurological disease is Sage’s last, best hope after failures in depression

6 months ago

Novartis strikes radiopharma deal with Ratio worth up to $745M

6 months ago

Eisai terminates Phase 3 trial of Dravet drug, citing recruitment challenges

6 months ago

European drug regulators offer wave of positive recommendations following Leqembi reversal

6 months ago

Adaptimmune to 'redefine' itself as a sarcoma biotech, cuts a third of staffers

6 months ago

Eli Lilly sues the US government over its proposed 340B rebate model

6 months ago

Trump picks vaccine skeptic Kennedy to lead HHS, in what would be an upheaval of US health policy

6 months ago

FDA says Merz's social media promotion with Nate Berkus is 'misleading'

6 months ago

Gilead will close Philadelphia, Seattle offices as part of job reductions

6 months ago

European drug regulator reverses opinion on Eisai and Biogen's Alzheimer's drug

6 months ago

Louisiana's Bill Cassidy named next chair of Senate health committee

6 months ago

As bluebird projects more commercial demand, the biotech continues to seek cash

6 months ago

BeiGene will rebrand to BeOne Medicines, dropping name's link to China roots

6 months ago

Merck KGaA’s life science unit is still feeling the Covid demand decline

6 months ago

Merck buys into PD-1/VEGF space as Summit comes for Keytruda

6 months ago

FDA approves PTC’s ultra-rare disease gene therapy for broader patient population than Europe

6 months ago

J&J takes 340B fight with federal government to court

6 months ago

After stock slides, Amgen addresses bone density talk on obesity drug

6 months ago

New cancer class heats up as BioNTech buys out China partner and its PD-L1/VEGF drug

6 months ago

Pfizer looking to sell hospital drugs unit — reports

6 months ago

AstraZeneca CEO reaffirms commitment to China following executive's detention

6 months ago

Syndax's menin inhibitor succeeds in pivotal trial, but investors aren't impressed

6 months ago

First page Previous page 25 26 272829 30 31 Next page Last page